~hyperlinks

it’s less people’s data, sure there is going to be some patient trial records, etc, but this isn’t very interesting as the juicy stuff is probably documented in medical literature anyway.

the big loss to the company would be the synthesis pathways and records of novel molecules that took them many years to research. even just directional research data could speed up rival pharma research. the actual value on keeping this stuff secret is easily in the billions of dollars.

ZezzebbulTheMysterious

undisclosed drug programs, proprietary compound structures, the Dicerna RNAi pipeline, private AI models, and other data.

well, at least this kind of stuff gives them a very strong incentive to better their security, as opposed to the "oops, we lost our customers' records again"

security

tech

Group Claims Novo Nordisk Hack stealing 1.3 terabytes of data asking $25m ransom

k00b

> undisclosed drug programs, proprietary compound structures, the Dicerna RNAi pipeline, private AI models, and other data.

well, at least this kind of stuff gives them a very strong incentive to better their security, as opposed to the "oops, we lost our customers' records again"